Article
Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients.
Drugs in R&D - 1 Dec 2015
Akpo Essè Ifèbi Hervé, Sbarigia Urbano, Wan George, Kleintjens Joris
Abstract excerpt
OBJECTIVE: Limited evidence is available on predictors of medical resource utilization (MRU) and related direct costs, especially in treatment-experienced patients infected with genotype 1 hepatitis C virus (HCV). This study aimed at investigating patient and treatment characteristics that predict MRU and related non-drug costs in treatment-experienced patients with chronic hepatitis C (CHC) treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
